Comments to FDA: NDI Notifications

Share page:
Docket Number:

CHPA believes that FDA’s revised 2016 Draft Guidance is an important step in helping to improve manufacturer understanding of, and compliance with, the new dietary ingredient notification requirement in Section 413 of the Federal Food, Drug, and Cosmetic Act.

Related Posts

CHPA Welcomes New Board Members at June Meeting